- Ticagrelor (Brilinta) is an antiplatelet medication that prevents dangerous blood clots from forming inside the arteries of the heart, particularly after a heart attack or coronary stent placement.
- It is almost always prescribed alongside low-dose aspirin, a combination known as dual antiplatelet therapy (DAPT), which provides stronger clot protection than either medicine alone.
- Unlike older antiplatelets such as clopidogrel, ticagrelor works directly and more quickly, producing a more consistent and reliable effect.
- The most common side effect is mild breathlessness, particularly in the first few weeks. It is usually not dangerous, but worth discussing with your doctor if it persists.
- The dose and duration of ticagrelor are individual decisions. Only your cardiologist, who knows your procedure and your overall clinical picture, can advise what is right for you.
- Never stop ticagrelor suddenly without speaking to your cardiologist first. Stopping abruptly can significantly increase the risk of a serious clot forming, particularly around a stent.
If you have recently had a heart attack or had a stent placed in one of your coronary arteries, you may have been prescribed a medication called ticagrelor, commonly known by the brand name Brilinta. It is completely understandable to want to know why you are taking it, how it works, and what to expect.
This article walks you through those questions in a clear and practical way. Understanding your medication is an important part of feeling confident about your recovery.
What Is Ticagrelor and Why Has It Been Prescribed?
Ticagrelor is an antiplatelet medication. Its main role is to prevent blood clots from forming inside the arteries of the heart. Platelets are small cells in your blood that normally help stop bleeding by clumping together. That is a vital function when you have a cut or injury, but it becomes a problem when platelets clump inside a narrowed or freshly stented artery, where they can trigger a dangerous blockage.
Ticagrelor reduces platelet activity to lower this risk. It is most commonly prescribed after a heart attack, unstable angina, or a coronary procedure such as stent placement. These are the situations where the risk of a new clot forming is highest, and your treating team will typically start it during your hospital admission.
While a new stent heals into the artery wall, ticagrelor is essential protection. It significantly reduces the risk of a clot forming around the stent before that healing is complete.
Dual Antiplatelet Therapy: Why Two Medicines?
Ticagrelor is almost always prescribed alongside low-dose aspirin. This combination is called dual antiplatelet therapy, or DAPT. The two medicines work through different pathways to block platelet activity, so together they provide significantly stronger protection than either one alone.
| Aspirin | Ticagrelor (Brilinta) | |
|---|---|---|
| How it works | Blocks the thromboxane A2 pathway, reducing platelet activation | Blocks the P2Y₁₂ receptor, preventing platelets from sticking together |
| Onset of action | Within 1 hour | Within 30 to 60 minutes, faster than clopidogrel |
| Dosing | 75 to 100mg once daily | 90mg twice daily (or 60mg twice daily long-term in some cases) |
| Reversibility | Irreversible. Platelets are affected for their lifetime | Reversible. Platelet function recovers within 3 to 5 days of stopping |
| Why combined | Different mechanisms provide complementary, stronger clot protection together | |
Your cardiologist will advise how long to continue DAPT based on your individual circumstances, typically 6 to 12 months. The exact duration varies depending on the type of stent used, your bleeding risk, and the nature of your heart condition. This decision is entirely individual, and only your cardiologist can advise on what is right for you.
How Does Ticagrelor Work?
Ticagrelor works by blocking a receptor on the surface of platelets called P2Y₁₂. This prevents platelets from becoming activated and clumping together.
Unlike older antiplatelet medicines such as clopidogrel, which needs to be converted into its active form by the liver before working, ticagrelor works directly. It acts more quickly and produces a more consistent, reliable antiplatelet effect. That is why it is generally preferred in the days and weeks immediately following a heart attack or stenting, when reliable protection matters most.
Another important difference is that ticagrelor’s effect on platelets is reversible. Once the medication is stopped, platelet function gradually returns to normal within three to five days. This becomes important if you ever need surgery, which we cover below.
How to Take It
Ticagrelor is usually taken as 90mg twice daily: once in the morning and once in the evening, approximately 12 hours apart. It is taken alongside a daily low-dose aspirin. After 12 months, some patients transition to a lower dose of 60mg twice daily for longer-term maintenance, depending on their circumstances.
Take it at the same times each day to keep its effect steady. It can be taken with or without food. If you miss a dose, take it as soon as you remember, unless it is almost time for the next one. In that case, skip the missed dose and continue your normal schedule. Do not take a double dose to make up for a missed one.
Twice daily, every day
Take ticagrelor morning and evening, about 12 hours apart, at the same times each day. Consistency keeps its protective effect steady.
Never stop suddenly
Stopping without guidance can allow a clot to form, particularly around a stent. Always speak to your cardiologist before any change.
Tell every clinician
Mention ticagrelor to every doctor, dentist, and pharmacist you see. It affects bleeding and interacts with several common medicines.
If You Need Surgery or a Procedure
This is one of the most important practical considerations for anyone on ticagrelor. Because it reduces the blood’s ability to clot, it needs to be carefully managed around any surgical procedure, including dental surgery, colonoscopy, and elective operations.
In most cases, ticagrelor should be stopped three to five days before a planned procedure to allow platelet function to recover. However, this decision should never be made without discussing it with both your cardiologist and the surgical or procedural team. Stopping antiplatelet therapy in the months after a stent procedure carries its own risk, and the timing must be carefully balanced.
If another specialist ever tells you to stop ticagrelor before a procedure, always loop in your cardiologist before doing so. This is a decision that requires coordination between your care teams.
Possible Side Effects
Most people tolerate ticagrelor well, but there are some side effects worth knowing about, particularly because a few of them can be unexpected if you are not prepared.
- Breathlessness or heavier breathing: the most commonly reported side effect, particularly in the first few weeks. It is usually mild and not related to a heart or lung problem. The exact mechanism is not fully understood, but it is thought to involve adenosine pathways in the body. For most people it eases over time. If it persists, worsens, or is accompanied by chest pain, speak to your doctor.
- Easy bruising: more common than usual due to reduced platelet activity. This is expected and not dangerous in itself.
- Nosebleeds or bleeding gums: mild bleeding from these sites is common. Apply gentle pressure and it should settle.
- Longer bleeding from cuts: small wounds may take longer to stop bleeding. Apply firm pressure for longer than usual.
- Headache or dizziness: occasionally reported, usually mild.
- Slow heart rate (bradycardia): a less common side effect, more relevant in people with existing rhythm issues.
- Serious bleeding: rare, but important to recognise. The warning signs are listed below.
When Should You Seek Help Urgently?
Contact your doctor or go to your nearest emergency department if you notice any of the following:
- Vomiting blood or material that looks like coffee grounds
- Black, tarry, or blood-stained stools
- Coughing up blood
- A cut that will not stop bleeding after prolonged firm pressure
- Sudden severe chest pain, especially after stopping ticagrelor
- Signs of stroke: sudden face drooping, arm weakness, or speech difficulty
Is Ticagrelor Suitable for Everyone?
Ticagrelor is not appropriate for everyone. Your cardiologist will have carefully considered your individual circumstances before prescribing it. It is generally not recommended, or requires extra caution, in the following situations:
| Situation | Why It May Be a Concern |
|---|---|
| History of significant bleeding (e.g. stomach ulcer) | Increased bleeding risk may outweigh the clot-prevention benefit |
| Prior haemorrhagic stroke (bleeding in the brain) | Antiplatelet therapy significantly increases the risk of recurrence |
| Severe liver disease | Affects how the medication is processed and cleared |
| Taking warfarin or a DOAC | Triple therapy significantly raises bleeding risk and requires specialist guidance |
| Severe asthma or COPD | The breathlessness side effect may be more problematic |
| Certain interacting medications | Some antibiotics, antifungals, and seizure medicines can affect ticagrelor levels |
If any of these apply to you, it does not necessarily mean ticagrelor is off the table, but it does mean the decision requires more careful discussion with your cardiologist, who may consider an alternative such as clopidogrel or a different DAPT approach. If you take an anticoagulant, our guide to warfarin and NOACs explains how these medicines differ from antiplatelets.
Common Questions
Can I drink alcohol while taking ticagrelor?
There is no direct interaction between alcohol and ticagrelor, but heavy drinking irritates the stomach lining and increases bleeding risk, which matters more when you are on an antiplatelet. If you drink, keep it modest and discuss your intake with your doctor, particularly if you have any history of stomach problems.
Can I take pain relief with it?
Paracetamol is generally the safest option for everyday pain relief. Anti-inflammatory medicines such as ibuprofen and naproxen increase bleeding risk and can irritate the stomach, so they should generally be avoided or used only with your doctor’s guidance while you are on DAPT.
Do I need any regular blood tests?
Ticagrelor does not require routine blood monitoring in the way warfarin does. Your cardiologist may check your kidney function, uric acid, or blood count from time to time as part of your general follow-up, but there is no regular test needed to measure the drug itself.
Heart Matters Resource
When in Doubt, Get Checked Out
If you notice unusual bleeding, worsening breathlessness, or anything that does not feel right while taking ticagrelor, do not wait it out. A prompt conversation with your GP or cardiologist is always the safest path.
Conclusion
Ticagrelor is a key part of modern heart care, particularly after a heart attack or stent procedure. It significantly reduces the risk of future events by protecting the arteries from dangerous clot formation during a critical period of healing.
Like any powerful medicine, it comes with side effects and considerations. With proper guidance, regular follow-up, and an understanding of what to expect, most people take it safely and effectively. If you are ever uncertain about your medication, notice concerning symptoms, or are facing another procedure, contact your cardiologist. Understanding your treatment is an important step in feeling confident about your recovery.
Related Reading
- What Is Clopidogrel Used For?
- Aspirin and Heart Health: What the Latest Evidence Shows
- Heart Stent Unboxing: What’s Inside the Tiny Device That Keeps Arteries Open
- Recovering After a Coronary Angiogram: What to Expect
- Stents or Bypass Surgery: How Your Heart Team Decides
- Blood Clots: What They Are, Why They Form, and How They’re Treated
- Understanding Your Cardiovascular Risk Factors
